User:Mr. Ibrahem/Dacarbazine

Dacarbazine (DTIC), also known as imidazole carboxamide, is a chemotherapy medication used in the treatment of melanoma and Hodgkin's lymphoma. For Hodgkin's it is often used together with vinblastine, bleomycin, and doxorubicin. It is given by injection into a vein.

Common side effects include loss of appetite, vomiting, low white blood cell count, and low platelets. Other serious side effects include liver problems and allergic reactions. It is unclear if use in pregnancy is safe for the baby. Dacarbazine is in the alkylating agent and purine analog families of medication.

Dacarbazine was approved for medical use in the United States in 1975. It is on the World Health Organization's List of Essential Medicines. The wholesale cost in the developing world is about US$7.45–18.24 per 200 mg vial. In the United Kingdom this dose costs the NHS about 7.50 pounds.